Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

This milestone event marks 10 years of amplifying the voices of lung cancer survivors, caregivers and advocates who have shared their personal stories with lawmakers to drive lifesaving change.

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

The following is a summary of “Mediating effects of coping strategies between symptom clusters and quality of life in lung ...

New robotic surgery systems in Oklahoma are transforming the fight against lung cancer—the deadliest form. Discover how early ...

LiveLung, a nonprofit organization dedicated to supporting lung cancer patients, survivors and their care partners, will present a program Wednesday on the importance of lung cancer screening and ...

This milestone event marks 10 years of amplifying the voices of lung cancer survivors, caregivers and advocates who have shared their personal stories with lawmakers to drive lifesaving change. "For ...